7d
Zacks Investment Research on MSNAlcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark ApprovalAlcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) ...
5d
Medical Device Network on MSNBausch + Lomb announces intraocular lens recallBausch + Lomb has reported a “voluntary recall” of certain intraocular lenses (IOLs) on its enVista platform due to ...
Alcon (ALC) announced that Vivity, the most widely implanted extended depth of focus intraocular lens, is now available on Alcon’s most ...
Hosted on MSN19d
Is it the Right Time to Hold Alcon Stock in Your Portfolio Now?Surgical Business Expands: In terms of the latest developments within Implantables, Alcon’s technology continues to lead the market, with every three IOLs (advanced intraocular lenses ...
Alcon's Future Looks Fruitful as New Innovation and Commercial Execution Spark Market Outperformance
Alcon also has a suite of advanced-technology intraocular lenses, or ATIOLs, that go beyond correcting vision issues at one distance. Although today’s global ATIOL market penetration rate by ...
(RTTNews) - Eye care firm Alcon Inc.(ALC) announced Tuesday that Vivity, an extended depth of focus or EDOF intraocular lens or IOL, is now available on the company's most advanced lens material ...
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities ...
The global implantable collamer lens market is set to experience remarkable expansion in the coming decade, driven by the increasing adoption of minimally invasive vision correction procedures. Market ...
Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) technology, has received CE Mark approval. The lens, made from Alcon's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results